These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7411170)

  • 1. Immunologic derangement in myotonic dystrophy--abnormal contact sensitization to dinitrochlorobenzene.
    Kuroiwa Y; Sugita H; Toyokura Y; Mizoguchi M; Matsuo H; Nonaka Y
    J Neurol Sci; 1980 Aug; 47(2):231-9. PubMed ID: 7411170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myotonic dystrophy and thymoma: a necropsy case report.
    Kuroiwa Y; Yamada A; Ikebe K; Kosaka K; Sugita H; Murakami T
    J Neurol Neurosurg Psychiatry; 1981 Feb; 44(2):173-5. PubMed ID: 7217976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoglobulin abnormalities in patients with myotonic dystrophy.
    Suzumura A; Yamada H; Matsuoka Y; Sobue I
    Acta Neurol Scand; 1986 Aug; 74(2):132-9. PubMed ID: 3490729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired delayed cutaneous hypersensitivity in thymoma.
    Révész T; Kardos G; Walcz E; Temesvári E; Schuler A; Péter F
    Pediatr Hematol Oncol; 1987; 4(2):163-5. PubMed ID: 3152922
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunoglobulin E in immunologic deficiency diseases. II. Serum IgE concentration of patients with acquired hypogammaglobulinemia, thymoma and hypogammaglobulinemia, myotonic dystrophy, intestinal lymphangiectasia and Wiskott-Aldrich syndrome.
    Waldmann TA; Polmar SH; Balestra ST; Jost MC; Bruce RM; Terry WD
    J Immunol; 1972 Aug; 109(2):304-10. PubMed ID: 5047372
    [No Abstract]   [Full Text] [Related]  

  • 6. Patients with myotonic dystrophy, a possible segmental progeroid syndrome, and Duchenne muscular dystrophy have fibroblasts with normal limits for in vitro lifespan and growth characteristics.
    Wertz RL; Hartwig GB; Frost AP; Brophy JJ; Atwater SK; Roses AD
    J Cell Physiol; 1981 May; 107(2):255-60. PubMed ID: 7251683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed cutaneous hypersensitivity ad peripheral blood lymphocyte counts in gastrointestinal cancer.
    Gupta S; Seth SK; Udupa KN; Sen PC
    Ann Acad Med Singap; 1980 Jan; 9(1):71-6. PubMed ID: 7447383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some aspects of cell-mediated hypersensitivity in patients with melanoma.
    Moszkowska G; Jassem J; Kondrat W; Kopacz A; Goszczyńska E
    Arch Immunol Ther Exp (Warsz); 1980; 28(4):655-60. PubMed ID: 6970028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Skin test for delayed type hypersensitivity].
    Haida M
    Nihon Rinsho; 1997 Mar; 55 Suppl 1():222-5. PubMed ID: 9097594
    [No Abstract]   [Full Text] [Related]  

  • 10. Delayed cutaneous hypersensitivity and blood lymphocyte count in advanced Hodgkin's and non-Hodgkin's lymphomas.
    Gupta S; Seth SK; Udupa KN; Sen PC; Rastogi BL
    Ann Chir Gynaecol; 1980; 69(2):79-83. PubMed ID: 7377739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral blood T and B lymphocytes, in vitro stimulation with phytohemagglutinin, and sensitization with 2,4-dinitrochlorobenzene in Grave's disease.
    Maciel RM; Miki SS; Nicolau W; Mendes NF
    J Clin Endocrinol Metab; 1976 Mar; 42(3):583-7. PubMed ID: 767355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune function of successfully treated lymphoma patients.
    King GW; Yanes B; Hurtubise PE; Balcerzak SP; LoBuglio AF
    J Clin Invest; 1976 Jun; 57(6):1451-60. PubMed ID: 932190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of transfer factor on lymphocyte function in anergic patients.
    Kirkpatrick CH; Rich RR; Smith TK
    J Clin Invest; 1972 Nov; 51(11):2948-58. PubMed ID: 5080419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed cutaneous hypersensitivity, lymphocyte count, and blood tests in patients with breast carcinoma.
    Lee YT
    J Surg Oncol; 1984 Nov; 27(3):135-40. PubMed ID: 6492808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-mediated immune competence in patients with prostatic carcinoma.
    Stefani SS; Menon M; Canning JR; Clark SS
    J Urol; 1978 Oct; 120(4):431-4. PubMed ID: 702665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed cutaneous hypersensitivity and peripheral lymphocyte counts in patients with advanced cancer.
    Lee YT; Sparks FC; Eilber FR; Morton DL
    Cancer; 1975 Mar; 35(3):748-55. PubMed ID: 1111942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Skin reactions of delayed hypersensitivity in melanoblastoma].
    Ryzhkov VI; Potapenkova LS; Korosteleva TA; Khachaturian LM
    Vopr Onkol; 1979; 25(4):3-6. PubMed ID: 433214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunology of sarcoidosis.
    James DG; Neville E; Walker A
    Am J Med; 1975 Sep; 59(3):388-94. PubMed ID: 169693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monocyte IgG-Fc receptors in myotonic dystrophy.
    Banerjee D; McClintock J; Silver MM; Hudson AJ
    Clin Exp Immunol; 1982 Dec; 50(3):572-8. PubMed ID: 7166000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immune defect following thymoma. Case description and review].
    Manzanell C; Morell A; Keller H
    Schweiz Med Wochenschr; 1985 Oct; 115(40):1393-401. PubMed ID: 2933805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.